Home » Electric Practices Ideas » Is Neuromelanin the Imaging Biomarker for the Early Diagnosis of Parkinson's Disease That We Were Looking for? - ePrints

Is Neuromelanin the Imaging Biomarker for the Early Diagnosis of Parkinson's Disease That We Were Looking for? - ePrints

David Miller • • 1 min read
Is Neuromelanin the Imaging Biomarker for the Early Diagnosis of Parkinson's Disease That We Were Looking for? - ePrints

Is neuromelanin the imaging biomarker for the early diagnosis of Parkinson's disease that we were looking for?

Lookup NU author(s): Professor Nicola PaveseORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).

Publication metadata

Author(s): Pavese N

Publication type: Editorial

Publication status: Published

Journal: Parkinsonism & Related Disorders

Year: 2019

Volume: 58

Pages: 1-2

Print publication date: 01/01/2019

Online publication date: 13/12/2018

Acceptance date: 12/12/2018

ISSN (print): 1353-8020

ISSN (electronic): 1873-5126

Publisher: Elsevier Ltd

URL:

DOI: 10.1016/j.parkreldis.2018.12.013

Share

David Miller
Author

David Miller

David Miller brings 15 years of experience in global economics, personal finance strategy, and market dynamics. He specializes in turning complex economic trends into actionable insights for everyday readers.